AUD 0.03
(0.0%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 5.13 Million AUD | -0.88% |
2023 | 5.18 Million AUD | -35.19% |
2022 | 7.99 Million AUD | 49.82% |
2021 | 5.33 Million AUD | -9.84% |
2020 | 5.91 Million AUD | 42.97% |
2019 | 4.13 Million AUD | -23.0% |
2018 | 5.37 Million AUD | 19.82% |
2017 | 4.48 Million AUD | -21.46% |
2016 | 5.71 Million AUD | 94.52% |
2015 | 2.93 Million AUD | -22.1% |
2014 | 3.76 Million AUD | 33.89% |
2013 | 2.81 Million AUD | 53.97% |
2012 | 1.82 Million AUD | -48.12% |
2011 | 3.52 Million AUD | 24.47% |
2010 | 2.83 Million AUD | -19.69% |
2009 | 3.52 Million AUD | -6.23% |
2008 | 3.75 Million AUD | -36.65% |
2007 | 5.93 Million AUD | -35.14% |
2006 | 9.15 Million AUD | -24.5% |
2005 | 12.11 Million AUD | 0.0% |
2003 | 15.51 Million AUD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 6.02 Million AUD | 0.0% |
2024 FY | 5.13 Million AUD | -0.88% |
2024 Q4 | 5.13 Million AUD | 0.0% |
2023 Q2 | 6.56 Million AUD | 0.0% |
2023 Q4 | 5.18 Million AUD | 0.0% |
2023 FY | 5.18 Million AUD | -35.19% |
2022 FY | 7.99 Million AUD | 49.82% |
2022 Q2 | 8.87 Million AUD | 0.0% |
2022 Q4 | 7.99 Million AUD | 0.0% |
2021 FY | 5.33 Million AUD | -9.84% |
2021 Q4 | 5.33 Million AUD | 0.0% |
2021 Q2 | 5.52 Million AUD | 0.0% |
2020 Q4 | 5.91 Million AUD | 0.0% |
2020 FY | 5.91 Million AUD | 42.97% |
2020 Q2 | 5.49 Million AUD | 0.0% |
2019 FY | 4.13 Million AUD | -23.0% |
2019 Q2 | 4.79 Million AUD | 0.0% |
2019 Q4 | 4.13 Million AUD | 0.0% |
2018 Q2 | 6.33 Million AUD | 0.0% |
2018 FY | 5.37 Million AUD | 19.82% |
2018 Q4 | 5.37 Million AUD | 0.0% |
2017 Q4 | 4.48 Million AUD | 0.0% |
2017 FY | 4.48 Million AUD | -21.46% |
2017 Q2 | 5.39 Million AUD | 0.0% |
2016 Q4 | 5.71 Million AUD | 0.0% |
2016 Q2 | 4.46 Million AUD | 0.0% |
2016 FY | 5.71 Million AUD | 94.52% |
2015 Q2 | 3.56 Million AUD | 0.0% |
2015 FY | 2.93 Million AUD | -22.1% |
2015 Q4 | 2.93 Million AUD | 0.0% |
2014 Q2 | 3.17 Million AUD | 0.0% |
2014 FY | 3.76 Million AUD | 33.89% |
2014 Q4 | 3.76 Million AUD | 0.0% |
2013 FY | 2.81 Million AUD | 53.97% |
2013 Q4 | 2.81 Million AUD | 0.0% |
2012 FY | 1.82 Million AUD | -48.12% |
2012 Q4 | 1.82 Million AUD | 0.0% |
2011 Q4 | 3.52 Million AUD | 0.0% |
2011 FY | 3.52 Million AUD | 24.47% |
2010 Q4 | 2.83 Million AUD | 0.0% |
2010 FY | 2.83 Million AUD | -19.69% |
2009 FY | 3.52 Million AUD | -6.23% |
2009 Q4 | 3.52 Million AUD | 0.0% |
2008 FY | 3.75 Million AUD | -36.65% |
2008 Q4 | 3.75 Million AUD | 0.0% |
2007 FY | 5.93 Million AUD | -35.14% |
2007 Q4 | 5.93 Million AUD | 0.0% |
2006 FY | 9.15 Million AUD | -24.5% |
2006 Q4 | 9.15 Million AUD | 0.0% |
2005 Q4 | 12.11 Million AUD | 0.0% |
2005 FY | 12.11 Million AUD | 0.0% |
2003 FY | 15.51 Million AUD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
4DMedical Limited | 120.01 Million AUD | 95.722% |
Adherium Limited | 9.88 Million AUD | 48.068% |
Aroa Biosurgery Limited | 101.82 Million AUD | 94.957% |
Atomo Diagnostics Limited | 11.37 Million AUD | 54.876% |
Anteris Technologies Ltd | 45.7 Million AUD | 88.765% |
Control Bionics Limited | 9.02 Million AUD | 43.121% |
CardieX Limited | 12.64 Million AUD | 59.409% |
Compumedics Limited | 40.35 Million AUD | 87.277% |
Cochlear Limited | 2.74 Billion AUD | 99.813% |
CleanSpace Holdings Limited | 26.05 Million AUD | 80.291% |
Cyclopharm Limited | 45.91 Million AUD | 88.817% |
EMVision Medical Devices Ltd | 23.97 Million AUD | 78.58% |
Nova Eye Medical Limited | 29.88 Million AUD | 82.817% |
HeraMED Limited | 2.95 Million AUD | -73.932% |
Imricor Medical Systems, Inc. | 12.17 Million AUD | 57.83% |
ImpediMed Limited | 46.98 Million AUD | 89.072% |
InhaleRx Limited | 1.57 Million AUD | -225.618% |
LBT Innovations Limited | 7.93 Million AUD | 35.259% |
Micro-X Limited | 26.89 Million AUD | 80.909% |
Neurotech International Limited | 12.21 Million AUD | 57.959% |
OncoSil Medical Limited | 6.71 Million AUD | 23.574% |
PolyNovo Limited | 109.16 Million AUD | 95.297% |
Respiri Limited | 6.19 Million AUD | 17.062% |
SomnoMed Limited | 69.8 Million AUD | 92.644% |
Universal Biosensors, Inc. | 30.12 Million AUD | 82.953% |
Visioneering Technologies, Inc. | 11.2 Million AUD | 54.177% |